Drexel's Office of Research & Innovation maintains a list of governmental, industry and foundation sponsorship opportunities for researchers in all topic areas.
Foundation & Corporate Relations (FCR) in the Office of Institutional Advancement builds and maintains partnerships with private and corporate foundations and serves as a resource to investigators during the grant proposal development process.
FCR and the College of Medicine will provide investigators with up-to-date funding opportunities available through foundations. The following requests for proposals (RFPs) are listed by submission deadline. Some foundations have recurring deadlines; others may have rolling deadlines.
There are some foundations that limit the number of applications an institution may submit for specific funding opportunities. Therefore, FCR facilitates limited submissions funding opportunities through Drexel’s InfoReady portal and will make known any funding opportunities that require an internal competition.
Investigators interested in pursuing a foundation or corporate grant should contact, executive director, Foundation & Corporate Relations – STEM Unit, pib25@drexel.edu, 215-895-0326.
METAvivor
Translational Research Award
Deadline: Letter of intent due: March 11, 2024
Invited applications due: August 22, 2024
Amount: Up to two years, $300,000 award
Career Stage: Established in field
Purpose:
METAvivor funds research focused on treating established breast cancer metastases to improve outcomes for stage IV metastatic breast cancer patients. We do not fund research that seeks to prevent or diagnose breast cancer metastasis, or that is focused on improving quality of life.
Eligibility:
All individuals with a clinical doctoral degree or with a doctoral degree who are actively engaged in areas of metastatic breast cancer research and treatment are eligible to apply.
METAvivor
Early Career Investigator Award
Deadline: Letter of Intent due March 12, 2024
Invited Applications due: August 21, 2024
Amount: Up to $200,000 over two years
Career Stage: Early Career Investigator Award and Emerging in Field
Purpose: METAvivor funds research focused on treating established breast cancer metastases to improve outcomes for stage IV metastatic breast cancer patients. We do not fund research that seeks to prevent or diagnose breast cancer metastasis, or that is focused on improving quality of life.
Eligibility: Investigators must be within 10 years of their degree award date and within 6 years of starting their first non-tenured position if started
The Mark Foundation for Cancer Research
Endeavor Award
Deadline: March 12, 2024, letter of intent
Funding: $3,000,000 over three years
Career Stage: All career stages
Purpose:
The Mark Foundation Endeavor Awards support collaborative research projects that bring together investigators with diverse areas of expertise to tackle challenges in the prevention, diagnosis and treatment of cancer. These grants are awarded to teams of three or more investigators to generate and integrate data from diverse lines of research and transform those insights into advances for cancer patients that could not be achieved by individual efforts.
Eligibility:
Institutional Eligibility:
- Teams may comprise investigators from a single institutions or multiple institutions.
- There is no requirement to include a U.S.-based institution as part of the team.
- Institutions may submit more than one application.
Investigator Eligibility:
- There are no restrictions on citizenship or geography.
- Applicants must have an independent faculty research appointment (tenure-track or equivalent) at a nonprofit academic institution.
- Investigators may be co-PI or collaborator on more than one proposal but may only serve as principal investigator on one proposal.
- Investigators who are currently a co-PI on an Endeavor team are permitted to apply as co-PI or collaborator on a new application.
Brain & Behavior Research Foundation
Young Investigator Grant
Deadline: March 12, 2024, 11:59 p.m. ET
Funding: $70,000 over two years
Career Stage: Early career
Purpose:
The Brain & Behavior Research Foundation is committed to alleviating the suffering caused by mental illness by awarding grants that will lead to advances and breakthroughs in scientific research. BBRF invests in the most innovative ideas in neuroscience and psychiatric research to better understand the causes and develop new ways to treat brain and behavior disorders. The grant enables promising investigators to either extend research fellowship training or begin careers as independent research faculty. Basic and/or clinical investigators are supported, but research must be relevant to serious brain and behavior disorders such as schizophrenia, mood disorders, anxiety disorders or child and adolescent mental illnesses.
Eligibility:
- Applicants must have a doctoral level degree (e.g., MD with [minimum PGY4] training, PhD, PsyD, PharmD, etc.) and already be employed in research training or a faculty research position. The YI Grant is intended to support advanced postdoctoral fellows, instructors and assistant professors (or equivalent). Predoctoral students, first-year postdoctoral fellows or faculty who serve(d) as a principal investigator (PI) on an NIH R01 grant are not eligible. Investigators at the rank of associate professor or equivalent are also not eligible (assistant professors who serve(d) as a principal investigator (PI) on a NIH R01 or equivalent grant are now eligible for the BBRF Independent Investigator Grant).
- Applicants must have an on-site mentor or senior collaborator who is an established investigator in areas relevant to psychiatric disorders. The mentor/sponsor role is usually extensive for fellowship extension (mentor), and more senior colleague/advisor (sponsor) for an applicant prepared to initiate independent science.
- Applicants may only apply twice for an initial BBRF Young Investigator Grant
Damon Runyon Cancer Research Foundation
Damon Runyon Fellowship Award
Deadline: March 15, 2024
Funding:
Year of Award |
Stipend |
Expenses |
Year 1 |
$70,000 |
$2,000 |
Year 2 |
$72,000 |
$2,000 |
Year 3 |
$74,000 |
$2,000 |
Year 4 |
$76,000 |
$2,000 |
Purpose:
The Foundation encourages all theoretical and experimental research relevant to the study of cancer and the search for cancer causes, mechanisms, therapies and prevention.
Candidates must apply for the fellowship under the guidance of a sponsor—a scientist (tenured, tenure-track or equivalent position) capable of providing mentorship to the fellow. In addition to aiding in the planning, execution and supervision of the proposed research, the sponsor’s role is to foster the development of the fellow’s overall knowledge, technical and analytical skills, and capacity for scientific inquiry. The sponsor is also expected to assist the fellow in attaining their career goals.
Awards are made to institutions for the support of the fellow under direct supervision of the sponsor. Candidates who have already accepted a postdoctoral research fellowship award are not eligible. (Candidates may hold a T32 at the time of application, but not concurrently with the Damon Runyon Fellowship Award.)
Eligibility:
Applicants must have completed one or more of the following degrees or their equivalent: MD, PhD, MD/PhD, DDS, DVM, DO. The applicant must include a copy of their diploma to confirm date of conferral. (If an applicant has not yet received their PhD diploma but has successfully completed all PhD requirements, including PhD defense, they may submit a letter from the graduate school explicitly stating such, with the date of the successful PhD defense and date of degree conferral.)
Level 1: Basic and physician-scientists must have received their degrees no more than 18 months prior to the application deadline date. Applicants must not have been in their sponsors' labs for more than one year prior to the application deadline date and are expected to devote 100% of their time to Damon Runyon-supported research activities.
Charles E. Kaufman Foundation, The Pittsburgh Foundation
Focus: New Initiative Research Grants (Interdisciplinary)
Deadline: March 22, 2024, 11:59 p.m. – letter of intent
If invited, proposal due May 20, 2024
Amount: $300,000 over two years ($150,000 per year)
Purpose:
The goal of the New Initiative Research Grants program is to stimulate existing investigators with strong records of research accomplishments to establish collaborations that facilitate innovative interdisciplinary approaches toward a common research question and that require expertise beyond that of any single researcher. Investigators may be at different institutions in Pennsylvania or at the same institution in Pennsylvania, provided that different approaches are combined to address a new research initiative. Proposals are required to address basic (fundamental, pure) questions addressing core principles in biology, physics and chemistry or at the disciplinary boundaries between these fields. Competitive submissions are expected to be rich in innovative ideas and approaches with the potential for generating transformative intellectual advances.
Eligibility
- There must be at least two investigators identified on the research project. All principal and co-investigators must hold primary appointments within a Pennsylvania institution of higher education. One faculty member must be identified at the principal investigator, and the PI’s institution as the lead institution. Other investigators should be identified as co-investigators.
- All principal and co-investigators must be either United States citizens or lawful permanent residents by the LOI deadline.
- NEW FOR 2024: Investigators must have one of the following:
- Full-time tenure
- Tenure-track appointment
- Independent research faculty appointment (with evidence of an independent research program)
- The investigators should reflect expertise in distinct disciplines or subdisciplines in biology, chemistry or physics. While these disciplines and subdisciplines can be broadly defined, it should be clear that different approaches are represented at addressing a specific research question. Please indicate the discipline(s) in which the research is grounded.
- The proposed research must be a new initiative and not currently funded from other sources.
ATTEND AN INFORMATION SESSION
Two virtual information sessions that feature an overview of the history and structure of all Kaufman grants programs, including New Initiative grants, New Investigator grants and Integrated Research-Education grants. Attendance is encouraged but not mandatory.
Charles E. Kaufman Foundation, The Pittsburgh Foundation
Focus: New Investigator Research Grants
Deadline:
March 22, 2024, 11:59 p.m. – letter of intent
If invited, proposal due May 20, 2024
Amount: $150,000 over two years ($75,000 per year)
Purpose:
The goal of the New Investigator Research Grants program is to provide research support for innovative scientists in Pennsylvania as they transition into an academic position as a new independent investigator. Proposals are required to address basic (fundamental, pure) questions addressing core principles in biology, physics and chemistry or at the disciplinary boundaries between these fields. Competitive submissions are expected to be rich in innovative ideas and approaches with the potential for generating transformative intellectual advances.
Eligibility
- Investigators whose primary appointment is at an institution of higher education in Pennsylvania.
- Applicants must be United States citizens or lawful permanent residents by the time of the LOI deadline.
- *NEW FOR 2024 - Investigators must have one of the following:
- Full-time tenure
- Tenure-track appointment
- Independent research faculty appointment (with evidence of an independent research program)
- *NEW FOR 2024 - Applicants must:
- Have not yet competed successfully as a PI to receive substantial independent NIH funding
- Have obtained a terminal research degree or terminal clinical degree within the past 10 years (an investigator can request an extension of their New Investigator status past the 10-year window due to extenuating circumstances such as childbirth, family care responsibilities, medical concerns, disability, extended periods of clinical training, natural disasters and active-duty military service)
ATTEND AN INFORMATION SESSION
Two virtual information sessions that feature an overview of the history and structure of all Kaufman grants programs, including New Initiative grants, New Investigator grants, and Integrated Research- Education grants. Attendance is encouraged, but not mandatory.
Melanoma Research Alliance
Next Steps Program
Deadlines:
|
Advancing Drug Discovery to Identify New Therapies |
Diagnostic and Prognostic Biomarker Identification |
Characterization of Rare Melanoma Preclinical Models |
RFA Released: |
Now available |
4/1/2024 |
6/17/2024 |
Proposals Due: |
3/28/2024, 11:59 p.m. ET |
6/6/2024, 11:59 p.m. ET |
8/19/2024, 11:59 p.m. ET |
Upcoming deadline: 3/28/24, 11:59 p.m. ET (Advancing Drug Discovery to Identify New Therapies)
Funding: Up to $250,000 depending on the scope of the research project with potential for follow-on funding; over one to two years.
Purpose:
The intent of this funding strategy is to help advance translation of discoveries into the clinic by supporting: 1) needed preclinical resources and tools for the research community to identify and begin to develop new therapies and 2) infrastructure to analyze and build large datasets to identify better diagnostic and prognostic biomarkers leading to hypothesis-driven research proposals for submission to MRA and other funding agencies.
Advancing Drug Discovery to Identify New Therapies: Drug discovery efforts against validated targets to support new therapeutic entity identification, optimization and testing in preclinical models, with an emphasis on targets including adapter proteins, transcription factors, cell surface proteins, etc. (e.g., CRKL, TERT, GAB2, YAP, LZTR, B7H3).
Diagnostic and Prognostic Biomarker Identification: Analysis and/or validation of large multi-institutional datasets to advance improvements in early detection and diagnosis across different skin types and identify prognostic biomarkers at different stages of the disease.
Characterization of Rare Melanoma Preclinical Models: Characterization of rare melanoma cell lines and PDX models with different molecular assays and drug sensitivity tests with the goal of making the models and corresponding data available to the research community to enable more preclinical research in rare melanomas.
Eligibility:
- MRA encourages applications from a diverse pool of investigators with respect to race, gender, sexual orientation, ethnicity, national origin and disability. MRA recognizes that diversity in the biomedical research workforce is critical for ensuring that the most creative minds have the opportunity to contribute to realizing our research goals and to ensuring more equitable health outcomes for all.
- Principal investigators (PIs) must hold a full-time faculty appointment at the level of assistant professor (or equivalent) or above.
- Fellows/postdocs or those in other training or research support positions are not eligible to apply as a PI.
- Individuals employed by state or federal government agencies may reach out to Joan Levy, MRA chief science officer (jlevy@curemelanoma.org) to determine their eligibility.
- An investigator may serve as PI on only one proposal submitted to the Next Steps RFA call in any given calendar year.
- Multiple applications will be accepted from a single institution, provided that each application has a different PI and represents a distinct project.
- Researchers who have not received prior MRA awards but who have projects that fit within the scope of this RFA are eligible to apply.
Breast Cancer Alliance
Exceptional Project Grants
Limited Submission: Two LOIs per institution
Deadline: Letter of Intent due March 31, 2024
If invited, full applications due July 19, 2024, midnight EDT
Amount: $100,000
Career Stage: All career stages
Purpose:
This award recognizes creative, unique and innovative research. The term of the Exceptional Project Grant is one year, beginning on March 1, 2025.
Prior to submission of a formal grant proposal, BCA requires a one-page letter of intent (LOI) and a separate CV. For 2024 grants, those letters will be due on March 31, 2024, and should be emailed to researchgrants@breastcanceralliance.org. The LOI must contain the applicant’s name, job title and institution at the top of the page, and the applicant’s contact information. The document should state the project title and hypothesis, outline the research aim(s) and methods, and include a brief discussion of the project’s potential impact. The CV should be in the current NIH biosketch format.
The grant provides salary support and project costs for a total of $100,000 (distributed over the one-year period as noted above.) Indirect costs, which are included in the $100,000 award, must be limited to 8% of total direct costs.
Eligibility:
Breast Cancer Alliance invites clinical doctors and research scientists at any stage of their careers, including postdocs, whose current proposal is focused on breast cancer, to apply for an Exceptional Project Grant
Breast Cancer Alliance
Young Investigator Grants
Limited Submission: 2 LOIs per institution
Deadline: Letter of Intent due March 31, 2024
If invited, full application due July 19, 2024, EDT
Amount: Two-year grant for a total of $125,000
Career Stage: Early career state, postdocs
Purpose:
This grant is intended to help advance the careers of young researchers who do not yet have their own major grant support but who design and conduct their own independent research projects.
The term of the Young Investigator Grant is two years, beginning on March 1, 2025. The grant provides salary support and project costs for a total of $125,000 (distributed over the two-year period as noted above.) Indirect costs, which are included in the $125,000 award, must be limited to 8% of total direct costs.
Eligibility:
To encourage a commitment to breast cancer research, Breast Cancer Alliance invites clinical doctors and research scientists who are in the early stages of their careers, including postdocs, whose current proposal is focused on breast cancer, to apply for funding for the Young Investigator Grant.
Applicants for the 2025 award must (1) not have held a tenure-track faculty or tenure-track research position for more than four years following completion of their training, as of March 1, 2025; (2) not have been or are not a principal investigator on an NIH R01 or equivalent national/international non-mentored award as of March 1, 2025; and (3) dedicate at least 50% of their work effort to research.
Multiple Myeloma Research Foundation
2024 Scholars Program
Deadline: March 31, 2024
Award:
The Scholars Program will provide up to $400,0000 of financial support over four (4) years ($100,000/year) plus 10% indirect costs (total award $440,000) to successful applicants.
Purpose:
The Multiple Myeloma Research Foundation (MMRF) seeks proposals for the MMRF 2024 Scholars Program. The goal of this initiative is to engage and support the careers of promising Black/African American clinical and/or laboratory investigators in the field of multiple myeloma research. The Scholars Program will support the awardee from postdoctoral training to first faculty-track position
Eligibility:
Applicants for the MMRF Scholars Program must have an MD and/or PhD or equivalent degree(s) and have completed at least one year of postdoctoral training and not hold a title higher than assistant professor or equivalent at a U.S. institution at the time of the award. Applicant must propose a clinical, translational, or basic science project relevant to the field of multiple myeloma.
America Heart Association
The Ralph L. Sacco Scholars Program in Brain Health
Deadline: April 9, 2024, 3 p.m. Central Time
Funding: $150,000 over twoyears
Purpose:
The Ralph L. Sacco Scholars Program in Brain Health (“The Sacco Scholars”) is a transformative new career development opportunity jointly supported by the American Academy of Neurology and the American Heart Association/American Stroke Association. This prestigious scholarship aims to empower the next generation of researchers and practitioners in the field of brain health, with a specific focus on the prevention of brain diseases and advancement of brain health for all.
The Sacco Scholars Program offers a unique opportunity for early career trainees to undertake a mentored two-year research project targeting various aspects of brain health. The scholarship program is designed to encompass various training career stages each year, ensuring inclusivity and fostering diverse perspectives. In the current call for proposals, we welcome submissions from MD or PhD (or equivalent doctoral degree) applicants who are (or will be) in postdoctoral fellowship training with a focus on brain health beginning July 1, 2024.
The program's scope of brain health emphasizes preventive approaches across the lifespan and encompasses a wide range of areas including healthy brain development and aging; attaining and maintaining optimal cognitive function and mental well-being; and primordial, primary and secondary prevention of neurological and mental health disorders. We strongly encourage projects that prioritize health equity, diversity and inclusion, as inspired by Dr. Sacco’s lifelong work in this area and aligning with our organizational commitments to advance these crucial values in brain health research and practice.
Note:
- Each candidate must be supported by a primary mentor with appropriate expertise to guide them through the project. Mentors should possess doctoral or equivalent level training and hold a faculty or staff appointment at the sponsoring institution.
- A webinar will be offered for interested applicants before the deadline. The webinar will be recorded and posted on the funder’s web page.
- Applicants must be American Heart Association professional members or members of the American Academy of Neurology at the time of application.
Whitehall Foundation
Deadline: April 15, 2024
If invited, full proposal due September 1, 2024
Note: This funder has three deadlines annually.
Amount:
- Research Grants: Up to $100,000 per year for the two- and three-year research grants.
- Grants-in-Aid: Up to $30,000 for a one-year period.
Career Stage:
The Foundation emphasizes the support of young scientists at the beginning of their careers and productive senior scientists who wish to move into new fields of interest.
Purpose:
The Foundation is currently interested in basic research in neurobiology, defined as follows: Invertebrate and vertebrate (excluding clinical) neurobiology, specifically investigations of neural mechanisms involved in sensory, motor and other complex functions of the whole organism as these relate to behavior. The overall goal should be to better understand behavioral output or brain mechanisms of behavior.
The Foundation does not support research focused primarily on disease(s) unless it will also provide insights into normal functioning.
The Foundation will accept only one letter of intent per twelve month period per investigator.
Two Types of Grant Programs:
- Research Grants
Research grants are available to established scientists of all ages working at accredited institutions in the United States. Applications will be judged on the scientific merit and the innovative aspects of the proposal as well as on the competence of the applicant. Research grants of up to three years will be provided. A renewal grant with a maximum of two years is possible, but it will be awarded on a competitive basis. Research grants will not be awarded to investigators who have already received, or expect to receive, substantial support from other sources, even if it is for an unrelated purpose.
- Grants-in-Aid
The Grants-in-Aid program is designed for researchers at the assistant professor level who experience difficulty in competing for research funds because they have not yet become firmly established. Grants-in-Aid can also be made to senior scientists. All applications will be judged on the scientific merit and innovative aspects of the proposal, as well as on past performance and evidence of the applicant’s continued productivity.
Eligibility:
The Foundation emphasizes the support of young scientists at the beginning of their careers and productive senior scientists who wish to move into new fields of interest.
The applicant must meet all of the following eligibility requirements in order to participate in the application process:
- Appropriate title: must be an assistant professor (or higher). If the institution does not use this title, a letter from the department chair confirming the applicant's eligibility is required.
- Status: must hold principal investigator status.
- Independent: must be considered an 'independent investigator' with their own dedicated lab space or with lab space independent of another investigator.
- The Foundation does not fund investigators who have substantial (approximately $200,000 per year) extramural funding. The Foundation uses the following formula to determine the PIs total extramural funding: Total direct per year plus total indirect per year less any PI salary taken from these grants. If this amount is greater than approximately $200,000 the PI would not be eligible for Whitehall Foundation funding. Startup funds and internal funding are not included in the calculation.
The Mark Foundation for Cancer Research
Emerging Leader Award
Deadline: April 29, 2024, 5 p.m. ET
If invited, full application due week of June 10, 2024
Funding: $250,000 per year for three years totaling $750,000
Career Stage: Early career and emerging in field
Purpose:
The Mark Foundation Emerging Leader Awards support innovative cancer research from the next generation of leaders. These grants are awarded to outstanding early career investigators to support high-impact, high-risk projects that are distinct from their current research portfolio.
Eligibility:
- MD, PhD or equivalent is required.
- Applicants must be employed by a U.S. or Canadian nonprofit academic institution.
- Applicants must be three to eight years from the start of an independent faculty research appointment as of December 31, 2024 (i.e., the official start date of the appointment must fall within the calendar years 2016-2021). Exceptions due to prolonged medical or family leave will be considered on a case-by-case basis.
- This award is not intended to be the main source of funding for the applicant’s laboratory. Applicants must demonstrate multi-year independent funding that sustains the central activities of the laboratory (e.g., at least one or two grants such as NIH/R01, NSF/CAREER, or equivalently substantial multi-year awards). Individual eligibility will be determined during the review process.
- Projects for this award must be centered on evidence-based laboratory, data, and/or medical science.
- Proposed projects must not be supported by other sources of funding. Finalists will be asked to discuss any potential overlap with other current or pending awards during the interview.
- Only one submission per applicant is permitted.
Elsa U. Pardee Foundation
Deadlines:
- April 30, 2024
- August 31, 2024
Career Stage: Postdocs, early and established career
Funding:
By design, there are no limits set on the amount that can be requested. It must be reasonably supported by the scope of the project outlined in the application. Indirect costs cannot exceed 5% of the total amount requested.
Description:
The Elsa U. Pardee Foundation funds research to investigators in United States nonprofit institutions proposing research directed toward identifying new treatments or cures for cancer. The foundation funds projects for a one-year period that will allow the establishment of capabilities of new cancer researchers or new cancer approaches by established cancer researchers. It is anticipated that this early-stage funding by the foundation may lead to subsequent and expanded support using government agency funding. Project relevance to cancer detection, treatment or cure should be clearly identified. The foundation particularly welcomes innovative, small-scale, short-term projects that may be difficult to fund elsewhere until some interesting results are obtained.
Eligibility:
Postdocs who are on the tenure track and have a tenured mentor are eligible. Priority is given to researchers at nonprofit institutions in the United States who are new to the field of cancer research, or to established research investigators examining new approaches to cancer cure.
W.W. Smith Charitable Trust
Limited Submission
A maximum of one proposal per parent organization may be submitted in each granting category (i.e., heart disease, cancer or AIDS) regardless of the number of EINs available under the organization.
Internal Competition Deadline: May 3, 2024, 11:59 p.m. EST
Funder’s Deadline: July 15, 2023, 11:59 p.m. EST
Focus: Heart disease, cancer and AIDS research
Amount: $125,000; Lower: $100,000
Grants are awarded for a one-year term. Awards typically range from $100,000 to $125,000 (including 10% indirect costs).
Description:
The trust awards grants for basic medical research primarily related to heart disease, cancer and AIDS. The trust identifies and funds research projects that are unique and meritorious. The trust invests in promising researchers having the potential to attract larger-scale awards (e.g., NIH, NSF, AHA) subsequent to trust support.
Pew Biomedical Scholars
Limited Submission: For the 2025 award, one nomination will be invited from each of the participating institutions.
Deadline:
Foundation opens nominations April 30, 2024. Nominations due to Pew May 15, 2024.
If invited, application due September 5, 2024
Funding:
The current grant level is $300,000; $75,000 per year for a four-year period.
Eligibility criteria:
- Hold a doctorate in biomedical sciences, medicine or a related field, including engineering or the physical sciences.
- As of September 5, 2024, run an independent lab and hold a full-time appointment at the rank of assistant professor. (Appointments such as research assistant professor, adjunct assistant professor, assistant professor research track, visiting professor or instructor are not eligible.)
- Must not have been appointed as an assistant professor at any institution prior to June 10, 2020, whether or not such an appointment was on a tenure track. Time spent in clinical internships or residencies, in work toward board certification, or on parental leave does not count as part of this four-year limit. Candidates who need an exception on the four-year limit should contact Pew’s program office to ensure that application reviewers are aware an exception has been given.
- Please note that the eligibility criteria above have been temporarily expanded to account for COVID-related lab shutdowns. Please direct any questions to the program office at scholarsapp@pewtrusts.org.
- May apply to the program a maximum of two times. All applicants must be nominated by their institution and must complete the 2025 online application.
- If applicants have appointments at more than one eligible nominating institution or affiliate, they may not reapply in a subsequent year from a different nominating entity.
- May not be nominated for the Pew Scholars Program and the Pew-Stewart Scholars Program for Cancer Research in the same year.